Australian Nobel Prize laureate Professor Barry Marshall has been honoured with one of China’s most prestigious international awards, recognising his work promoting scientific and technological cooperation between China and Australia.
The China International Science and Technology Cooperation Award, which is the nation’s highest scientific honour for foreign individuals or international organisations, was awarded to Professor Marshall in Beijing last week.
Known globally for his groundbreaking discovery of the Helicobacter pylori (H. pylori) bacterium and its association with peptic ulcer diseases, Professor Marshall’s laboratory has since developed enhanced methods for non-invasive studies on the molecular epidemiology of H. pylori, notably rapid breath test methods and retrieval of the organism (and culture) from a swallowed string.
The gastroenterologist is also founder and director of ONDEK, a biotechnology company developing new biologic delivery systems for vaccines and therapeutics utilising the unique characteristics of the gut bacterium, and TRI-MED, a diagnostics company developing H. pylori tests.
After helping reduce H. pylori prevalence in Australia, he shifted his focus to China, which accounts for half of the world’s gastric cancer cases, leading significant projects like the semi-automatic H. pylori culturing system and large-scale clinical trials.
His efforts have played a key role in enhancing medical diagnostics and treatment methods in China, including the establishment of research centres and partnerships, such as the Marshall Laboratory of Biomedical Engineering at Shenzhen University and collaborations with leading medical institutions.